• Go to navigation
  • Go to content
AstraZeneca Clinical Trials

Astrazeneca Worldwide

  • AstraZeneca Websites
AstraZeneca US

Main navigation

  • Home
  • Therapy Areas
    • Oncology/Infection
    • Cardiovascular
    • Gastrointestinal
    • Neuroscience
    • Respiratory/Inflammation
  • Drug Products
    • All Drug Products
  • Diseases & Conditions
    • All Diseases and Conditions
  • Glossary
  • Contact Us
  • Disclosure Commitment

You are here

  • Home
  • Drug Products
  • All Drug Products
  • Phase I, open label, healthy volunteers, ADME study with single oral administration of [14C] AZD8931

Drug Name
AZD8931
Generic Name
AZD8931
Sponsor
AstraZeneca
Drug Status
In Development
Phase
I
Start Date
Jan 18, 1971
Study Name
D0102C00007
Study Id
D0102C00007
ClinicalTrials.gov ID
NCT01284595
Recruiting Status
Open
Protocol Status
Not Available
Report Status
Not Available

Page tools

  • Print
  • Bookmark this page

Legal notices

  • Legal notice
  • Privacy policy
  • © AstraZeneca 2013